Changes in CArG-binding protein A expression levels following injection(s) of the D1-dopamine agonist SKF-82958 in the intact and 6-hydroxydopamine-lesioned rat

Neuroscience

Volumn 98, Issue 1, 2000, Pages 69-78

  Rushlow, W J ^a   Rajakumar, B ^a   Flumerfelt, B A ^a   Naus, C C G ^a   Rajakumar, N ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

D1 dopamine agonist; D1 dopamine receptors; Immediate early genes; Immunocytochemistry; In situ hybridization; Striatum

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; BINDING PROTEIN; CARG BINDING PROTEIN A; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR BLOCKING AGENT; FLUPHENAZINE; MESSENGER RNA; OXIDOPAMINE; PROTEIN C FOS; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CAUDATE NUCLEUS; CONTROLLED STUDY; GENE EXPRESSION; HYPERSENSITIVITY; IMMEDIATE EARLY GENE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUTAMEN; RAT;

ANIMALS; BENZAZEPINES; CORPUS STRIATUM; DENERVATION; DNA-BINDING PROTEINS; DOPAMINE AGONISTS; GENE EXPRESSION; GENES, IMMEDIATE-EARLY; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; IN SITU HYBRIDIZATION; MALE; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; REPRESSOR PROTEINS; RNA, MESSENGER; SYMPATHOLYTICS;

EID: 0034091198     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00104-4     Document Type: Article

References (50)

1. Boegman R.J., Vincent S.R. Involvement of adenosine and glutamate receptors in the induction of c-fos in the striatum by haloperidol. Synapse. 22:1996;70-77.
2. Changelian P.S., Feng P., King T.C., Milbrandt J. Structure of the NGFI-A gene and detection of upstream sequences responsible for its transcriptional induction by nerve growth factor. Proc. natn. Acad. Sci. U.S.A. 86:1989;377-381.
3. Christy B.A., Lau L.F., Nathans D. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc. natn. Acad. Sci. U.S.A. 85:1988;7857-7861.
4. Cole A.J., Bhat R.V., Patt C., Worley P.F., Baraban J.M. D1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J. Neurochem. 58:1992;1420-1426.
5. Comb M., Mermod N., Hyman S.E., Pearlberg J., Ross M.E., Goodman H.M. Proteins bound at adjacent DNA elements act synergistically to regulate human proenkephalin cAMP inducible transcription. Eur. molec. Biol. Org. J. 7:1988;3795-3805.
6. Deutch A.Y., Duman R.S. The effects of antipsychotic drugs on fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Neuroscience. 70:1996;337-389.
7. Dragunow M., Robertson G.S., Faull R.L., Robertson H.A., Jansen K. D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience. 37:1990;287-294.
8. Doucet J.P., Nakabeppu Y., Bedard P.J., Hope B.T., Nestler E.J., Jasmin B.J., Chen J.S., Iadarola M.J., St-Jean M., Wigle N., Blanchet P., Grondin R., Robertson G.S. Chronic alterations in dopaminergic neurotransmission produce a persistent elevation of deltaFosB-like protein(s) in both the rodent and primate striatum. Eur. J. Neurosci. 8:1996;365-381.
9. Gerfen C.R., Keefe K.A., Gauda E.B. D1 and D2 dopamine receptor function in the striatum: coactivation of D1- and D2-dopamine receptors on separate populations of neurons results in potentiated immediate early gene response in D1-containing neurons. J. Neurosci. 15:1995;8167-8176.
10. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. natn. Acad. Sci. U.S.A. 87:1990;6912-6916.
11. Hahn M., Hahn S.L., Stone D.M., Joh T.H. Cloning of the rat gene encoding choline acetyltransferase, a cholinergic neuron-specific marker. Proc. natn. Acad. Sci. U.S.A. 89:1992;4387-4391.
12. Hiroi N., Graybiel A.M. Atypical and typical neuroleptic treatments induce distinct programs of transcription factor expression in the striatum. J. comp. Neurol. 374:1996;70-83.
13. Hurley M.J., Stubbs C.M., Jenner P., Marsden C.D. Dopamine D3 receptors are not involved in the induction of c-fos mRNA by neuroleptic drugs: comparison of the dopamine D3 receptor antagonist GR103691 with typical and atypical neuroleptics. Eur. J. Pharmac. 318:1996;283-293.
14. Janknecht R., Cahill M.A., Nordheim A. Signal integration at the c-fos promoter. Carcinogenesis. 16:1995;443-450.
15. Kamada S., Miwa T. A protein binding to CArG box motifs and to single-stranded DNA functions as a transcriptional repressor. Gene. 119:1992;229-236.
16. Karin M., Liu Z.G., Zandi E. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:1997;240-246.
17. Keefe K.A., Gerfen C.R. D1-D2 dopamine receptor synergy in striatum: effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression. Neuroscience. 66:1995;903-913.
18. Keefe K.A., Gerfen C.R. D1 dopamine receptor-mediated induction of zif268 and c-fos in the dopamine-depleted striatum: differential regulation and independence from NMDA receptors. J. comp. Neurol. 367:1996;165-176.
19. Kiba H., Jayaraman A. Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation. Molec. Brain Res. 23:1993;1-13.
20. Kislauskis E., Dobner P.R. Mutually independent response elements in the cis-regulatory regions of the neurotensin/neuromedin N gene integrate environmental stimuli in PC12 cells. Neuron. 4:1990;783-795.
21. LaHoste G.J., Yu J., Marshall J.F. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity. Proc. natn. Acad. Sci. U.S.A. 90:1993;7451-7455.
22. Liu J., Nickolenko J., Sharp F.R. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc. natn. Acad. Sci. U.S.A. 91:1994;8537-8541.
23. MacGibbon G.A., Lawlor P.A., Bravo R., Dragunow M. Clozapine and haloperidol produce a differential pattern of immediate early gene expression in rat caudate-putamen, nucleus accumbens, lateral septum and islands of Calleja. Molec. Brain Res. 23:1994;21-32.
24. Mendelson S.C., Quinn J.P. Characterisation of potential regulatory elements within the rat preprotachykinin-A promoter. Neurosci. Lett. 184:1995;125-128.
25. Miller J.C. Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J. Neurochem. 54:1990;1453-1455.
26. Monstein H.J. Identification of an AP-1 transcription factor binding site in the human cholecystokinin (CCK) promoter. NeuroReport. 4:1993;195-197.
27. Moratalla R., Robertson H.A., Graybiel A.M. Dynamic regulation of NGFI-A (zif268, egr1) gene expression in the striatum. J. Neurosci. 12:1992;2609-2622.
28. Moratalla R., Vickers E.A., Robertson H.A., Cochran B.H., Graybiel A.M. Coordinate expression of c-fos and jun B is induced in the rat striatum by cocaine. J. Neurosci. 13:1993;423-433.
29. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. natn. Acad. Sci. U.S.A. 89:1992;4270-4274.
30. Nye H.E., Hope B.T., Kelz M.B., Iadarola M., Nestler E.J. Pharmacological studies of the regulation of chronic fos-related antigen induction by cocaine in the striatum and nucleus accumbens. J. Pharmac. exp. Ther. 275:1995;1671-1680.
31. Paul M.L., Graybiel A.M., David J.C., Robertson H.A. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
32. Robertson G.S., Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 46:1992;315-328.
33. Robertson G.S., Matsumura H., Fibiger H.C. Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmac. exp. Ther. 271:1994;1058-1066.
34. Robertson G.S., Jian M. D1 and D2 dopamine receptors differentially increase Fos-like immunoreactivity in accumbal projections to the ventral pallidum and midbrain. Neuroscience. 64:1995;1019-1034.
35. Robertson G.S., Fibiger H.C. Effects of olanzapine on regional C-Fos expression in rat forebrain. Neuropsychopharmacology. 14:1996;105-110.
36. Rushlow W.J., Naus C.C.G., Flumerfelt B.A. Colocalization of prosomatostatin-derived peptides in the caudate-putamen of rat. J. comp. Neurol. 349:1994;583-595.
37. Rushlow W., Rajakumar N., Naus C.C.G., Flumerfelt B.A. Elevated levels of CArG-binding protein mRNA in the striatum in neuroleptic-induced dyskinesia. Soc. Neurosci. Abstr. 23:1997;2044.
38. Rushlow W.J., Rajakumar N., Flumerfelt B.A., Naus C.C.G. Characterization of CArG-binding protein A initially identified by differential display. Neuroscience. 94:1999;637-649.
39. Sarig G., Weisman-Shomer P., Fry M. Telomeric and tetraplex DNA binding properties of qTBP42: a homologue of the CarG box binding protein CBF-A. Biochem. biophys. Res. Commun. 237:1997;617-623.
40. Semba J., Sakai M., Miyoshi R., Mataga N., Fukamauchi F., Kito S. Differential expression of c-fos mRNA in rat prefrontal cortex, striatum, N. accumbens and lateral septum after typical and atypical antipsychotics: an in situ hybridization study. Neurochem. Int. 29:1996;435-442.
41. Sharp F.R., Liu J., Nickolenko J., Bontempi B. NMDA and D1 receptors mediate induction of c-fos and junB genes in striatum following morphine administration: implications for studies of memory. Behav. Brain Res. 66:1995;225-230.
42. Simpson C.S., Morris B.J. Haloperidol and fluphenazine induce junB gene expression in rat striatum and nucleus accumbens. J. Neurochem. 63:1994;1955-1961.
43. Smidt M.P., Russchen B., Snippe L., Wijnholds J., Geert A.B. Cloning and characterisation of a nuclear, site specific ssDNA binding protein. Nucleic Acid Res. 23:1995;2389-2395.
44. Steiner H., Gerfen C.R. Dynorphin regulates D1 dopamine receptor-mediated responses in the striatum: relative contributions of pre- and postsynaptic mechanisms in dorsal and ventral striatum demonstrated by altered immediate-early gene induction. J. comp. Neurol. 376:1996;530-541.
45. Vahid-Ansari F., Nakabeppu Y., Robertson G.S. Contrasting effects of chronic clozapine, seroquel (ICI 204,636) and haloperidol administration on deltafosB-like immunoreactivity in the rodent forebrain. Eur. J. Neurosci. 8:1996;927-936.
46. Wan W., Ennulat D.J., Cohen B.M. Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in rat forebrain. Brain Res. 688:1995;95-104.
47. Wang J.Q., McGinty J.F. Scopolamine augments c-fos and zif/268 messenger RNA expression induced by the full D1 dopamine receptor agonist SKF-82958. Neuroscience. 72:1996;601-616.
48. Wang J.Q., McGinty J.F. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. J. Pharmac. exp. Ther. 281:1997;972-982.
49. Yoon S.O., Chikaraishi D.M. Tissue specific expression of the rat tyrosine hydroxylase gene requires synergy between an AP-1 motif and an overlapping E box-containing dyad. Neuron. 9:1992;55-67.
50. Young S.T., Porrino L.J., Iadarola M.J. Cocaine induces striatal c-Fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. natn. Acad. Sci. U.S.A. 88:1991;1291-1295.